Reported patient in this article is a rare case of simultaneous brain and pulmonary AVMs that presented in different ages with unusual symptoms.
The prevalence of sporadic congenital brain AVMs in retrospective studies has been about 1 - 5 in 1000 (
3). Most of them become symptomatic during life at different ages and will require careful attention and care even if they are accidentally diagnosed. Furthermore, 43 to 71% of these patients present with cerebral hemorrhage, 18 to 40% have seizures and 5 - 14% present with headaches (
6).
Our patient's symptoms were only headaches, which is one of the very rare manifestations of the disease. Another problem in this patient is the coexistence of progressive and extensive pulmonary AVMs, which is a very rare association and have caused such complications. In general, due to the severe complications seen in patients with PAVMs, most studies recommend the treatment of these lesions (
7,
8). However paradoxical emboli which may lead to stroke or brain abscess is a concern that indicate the need for intervention for patients with pulmonary AVMs (
9).
In general, 15 to 30% of brain abscesses are cryptogenic in nature, which can be caused by heart problems (
10).
However, due to the presence of a resistant blood-brain barrier and abundant cerebral circulation, the probability of these abscesses following pulmonary AVM is about 5% (
11), which was also observed in our patient, that can be due to the spread, reanalyzed and new lesion with a high volume of the shunt inside the lungs (
12).
Recurrence in pulmonary AV malformation after successful treatment is due to recanalization or reperfusion via pulmonary and bronchial arteries in about 25% of patients, and both of them have been reported in previous studies (
13,
14). In our case also both reperfusion and recanalization cause recurrence of AV malformation after 10 coil and 2 occluder device during three sessions of intervention.
Today, the standard treatment for these lesions is endovascular ligation, which has been performed in our patient over the years due to the recurrence of the disease, and the use of this number of devices in one patient has rarely been reported in studies.
The important thing in such a case is the timing and treatment of AVMs that has been one of the most challenging topics for the last 30 years. Several treatments such as surgical resection, embolization through intra-arterial, stereotactic radiosurgery (SRS) or a combination of methods have been proposed that vary based on the risk of cerebral hemorrhage as well as the risk of surgery (
3).
Large and diffuse lesions and those that are located in certain parts of the brain or have deep venous drainage have a high risk of surgery and complications, so alternative therapies such as endovascular can be used (
6).
But due to the unknown nature of the disease and the low annual rupture rate, it is very difficult to decide when to remove the brain AVMs. Due to the fact that mortality and morbidity due to cerebral hemorrhage following the rupture of these AVMS are high. However it is generally recommended to decide on the treatment of the patient immediately after diagnosis (
6).
Our patient was also a candidate for endovascular method with Onyx glue due to the presence of extensive lesions in different areas of the brain and presences of lung AVMs with cyanotic nature that increased the risk of surgery.
Endovascular treatment is one of the relatively new methods in closing these disorders in which materials such asn-butyl 2-cyanoacrylate (NBCA) and ethylene vinyl alcohol (EVOH) or Onyx adhesives are used. This method has fewer side effects and is used in cases where the lesions are large and diffuse. This is due to the fact that removing such lesions has the risk of mortality and irreversible brain complications (
3).
Safety and efficacy of endovascular methods in patients with AVMs has been proven, but due to high prevalence of complications and the risk of recurrence of long-term follow-up lesions, it is recommended to undergo high resolution CT scans every three to five years for lung lesions (
11). Furthermore, the use of anticoagulants have been reported to prevent brain damage, nevertheless whether these drugs are safe or not should be further investigated (
15).
To our best knowledge, our patient is the first reported case of simultaneous pulmonary and brain AV malformation with unusual presentations and no specific syndromic disease.
3.1. Conclusion
It can be concluded that patients with pulmonary AVMs, although sporadic, need careful examination for other congenital disorders and it is necessary to pay attention to the presence of these anomalies in other organs, even though it is rare. Another important issue is the risk of recurrence of these lesions as a result of recanalization, reperfusion or the formation of new lesions, which also makes endovascular treatment difficult. In general, due to the unknown nature of the disease and its progression, the treatment of these lesions is completely based on patients’ characteristics and varies according to each patient. Assessing the risk of surgery and its complications and comparing it with the endovascular method can also help the number of lesions in deciding the type of treatment.